NCT03556046 - 89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

December 17, 2018

Study Completion Date

December 17, 2018

Conditions

Clear Cell Renal Carcinoma

Interventions

DIAGNOSTIC_TEST

89Zr-Girentuximab

Single diagnostic injection on Day 0, followed by diagnostic scans on Days 3 and 7±1, as well as the whole body dosimetric imaging on Days 0, 1, 3 and 7±1

Trial Locations (1)

6525

Radboud University, Nijmegen